E-LIB Suche - Ergebnisse für: Roberts, Mary Scott

1

P255: Gain-of-function CASR variants, a common genetic caus..:

Mathew, Arun ; Sridhar, Ananth ; Roberts, Mary Scott...
Genetics in Medicine Open. 2 (2024) - p. 101151 , 2024

Link: https://doi.org/10.1016/..

2

P161: A genetics-first approach to identify novel variants ..:

Chang, Jeremy ; Soliai, Marcus ; Barnhill, Connor...
Genetics in Medicine Open. 2 (2024) - p. 101058 , 2024

Link: https://doi.org/10.1016/..

3

Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Link..:

Imel, Erik A ; Glorieux, Francis H ; Whyte, Michael P...
The Journal of Clinical Endocrinology & Metabolism. 108 (2023) 11 - p. 2990-2998 , 2023

Link: https://doi.org/10.1210/..

4

Burosumab Improves Patient-Reported Outcomes in Adults With..:

Jan de Beur, Suzanne M ; Cimms, Tricia ; Nixon, Annabel...
Journal of Bone and Mineral Research. 38 (2023) 11 - p. 1654-1664 , 2023

Link: https://doi.org/10.1002/..

5

The efficacy and safety of burosumab in two patients with c..:

Sugarman, Jeffrey ; Maruri, Ann ; Hamilton, Dale J....
Bone. 166 (2023) - p. 116598 , 2023

Link: https://doi.org/10.1016/..

6

OR21-2 Encaleret (CLTX-305) Restored Mineral Homeostasis in..:

Collins, Michael ; Fox, Jonathan ; Hartley, Iris...
Journal of the Endocrine Society. 6 (2022) Supplement_1 - p. A193-A194 , 2022

Link: https://doi.org/10.1210/..

7

Effects of Encaleret (CLTX-305) on Mineral Physiology in Au..:

Gafni, Rachel ; Hartley, Iris ; Roszko, Kelly...
Bone Reports. 16 (2022) - p. 101558 , 2022

Link: https://doi.org/10.1016/..

8

Effect of Burosumab Compared With Conventional Therapy on Y..:

Ward, Leanne M ; Glorieux, Francis H ; Whyte, Michael P...
The Journal of Clinical Endocrinology & Metabolism. 107 (2022) 8 - p. e3241-e3253 , 2022

Link: https://doi.org/10.1210/..

9

Burosumab Provides Sustained Improvement in Phosphorus Home..:

Gottesman, Gary ; Imel, Erik Allen ; Carpenter, Thomas O...
Journal of the Endocrine Society. 5 (2021) Supplement_1 - p. A251-A251 , 2021

Link: https://doi.org/10.1210/..

10

Population Pharmacokinetics and Pharmacodynamics of Burosum..:

Lee, Sun Ku ; Gosselin, Nathalie H. ; Taylor, Julie...
The Journal of Clinical Pharmacology. 62 (2021) 1 - p. 87-98 , 2021

Link: https://doi.org/10.1002/..

11

Diagnosis and Management of Tumor-induced Osteomalacia: Per..:

Dahir, Kathryn ; Zanchetta, María Belén ; Stanciu, Irinel...
Journal of the Endocrine Society. 5 (2021) 9 - p. , 2021

Link: https://doi.org/10.1210/..

12

Autosomal Dominant Hypocalcemia Type 1: A Systematic Review:

Roszko, Kelly L ; Stapleton Smith, Lyndsay M ; Sridhar, Ananth V...
Journal of Bone and Mineral Research. 37 (2020) 10 - p. 1926-1935 , 2020

Link: https://doi.org/10.1002/..

13

SUN-356 Burosumab Resulted in Greater Clinical Improvements..:

Ward, Leanne Marie ; Roberts, Mary Scott ; Chang, Ting..
Journal of the Endocrine Society. 4 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1210/..

14

Burosumab for the Treatment of Tumor-Induced Osteomalacia:

Jan de Beur, Suzanne M ; Miller, Paul D ; Weber, Thomas J...
Journal of Bone and Mineral Research. 36 (2020) 4 - p. 627-635 , 2020

Link: https://doi.org/10.1002/..

15

Reply to: Burosumab for Tumor-Induced Osteomalacia: not Eno..:

Jan de Beur, Suzanne M. ; Miller, Paul D. ; Weber, Thomas J....
Journal of Bone and Mineral Research. 36 (2020) 12 - p. 2455-2456 , 2020

Link: https://doi.org/10.1002/..